Stock Fundamentals

Company Information

Company Name
NextCure  Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US65343E1082
CIK: 0001661059
CUSIP: 65343E108
Currency: USD
Full Time Employees: 40
Phone: 240 399 4900
Fiscal Year End: December
IPO Date: May 09, 2019
Description:

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.

Address:

9000 Virginia Manor Road, Beltsville, MD, United States, 20705

Directors & Officers

Name Title Year Born
Mr. Michael S. Richman MSBA Co-Founder, CEO, President & Director 1961
Dr. Timothy Mayer Ph.D. Chief Operating Officer 1965
Dr. Udayan Guha M.D., Ph.D. Chief Medical Officer 1972
Dr. Lieping Chen M.D., Ph.D. Co-Founder & Chairman of Scientific Advisory Board 1957
Mr. Steven P. Cobourn CPA Chief Financial Officer 1963
Mr. Kevin G. Shaw Senior VP & General Counsel 1974
Mr. Sourav Kundu Ph.D. Senior Vice President of Development & Manufacturing 1961
Dr. Sebastien Maloveste Ph.D. Senior Vice President of Business Development NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 15, 2019 Sofinnova Venture Partners Ix, N/A Purchase 150.00K $36.75 $5.51M
May 13, 2019 Stella Xu N/A Purchase 125.00K $15.00 $1.88M
May 13, 2019 X L.P. Canaan N/A Purchase 50.00K $15.00 $750.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Squadron Capital Management LLC 265.00K Mar 31, 2026 7.34% $1.04 11.83%
Affinity Asset Advisors, LLC 241.83K Mar 31, 2026 6.69% $0.13 -2.21%
Ikarian Capital, LLC 238.30K Mar 31, 2026 6.60% $0.20 0.00%
Sofinnova Ventures 222.65K Mar 31, 2026 6.16% $0.09 0.00%
SILVERARC CAPITAL MANAGEMENT, LLC 176.06K Mar 31, 2026 4.87% $0.19 0.00%
Vanguard Capital Management, LLC 160.47K Mar 31, 2026 4.44% $0.00 0.00%
Pfizer Inc 153.35K Mar 31, 2026 4.25% $0.64 -2.72%
Opaleye Management Inc 141.18K Mar 31, 2026 3.91% $0.20 0.00%
Awm Investment Company Inc 117.37K Mar 31, 2026 3.25% $0.14 0.00%
Exome Asset Management LLC 115.50K Mar 31, 2026 3.20% $0.63 -30.00%
Vanguard Group Inc 91.91K Dec 31, 2025 2.54% $0.00 35.20%
BOOTHBAY FUND MANAGEMENT, LLC 69.62K Mar 31, 2026 1.93% $0.01 0.00%
Renaissance Technologies Corp 60.53K Mar 31, 2026 1.68% $0.00 79.98%
Verdad Advisers, LP 42.96K Mar 31, 2026 1.19% $0.52 0.00%
Geode Capital Management, LLC 31.09K Mar 31, 2026 0.86% $0.00 34.27%
BlackRock Inc 27.79K Mar 31, 2026 0.77% $0.00 0.00%
Woodline Partners LP 27.50K Mar 31, 2026 0.76% $0.00 0.00%
CARDIFF PARK ADVISORS, LLC 21.83K Mar 31, 2026 0.60% $0.02 0.00%
Acadian Asset Management LLC 18.98K Mar 31, 2026 0.53% $0.00 0.00%
Vanguard Fiduciary Trust Co 16.02K Mar 31, 2026 0.44% $0.00 0.00%

Shares Statistics

Shares Outstanding: 3.61M
Shares Float: 2.28M
% Insiders: 1,484.10%
% Institutions: 6,254.20%
Short % Float: 1.90%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 123.28K 3.41% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 33.69K 0.93% ▲ 0.00% Apr 30, 2026
3 Fidelity Extended Market Index 16.69K 0.46% ▼ 0.36% Apr 30, 2026
4 Nomura Healthcare Fund Class I 12.50K 0.35% ▲ 0.00% Apr 30, 2026
5 Spartan Extended Market Index Pool F 4.27K 0.12% ▲ 1.45% Apr 30, 2026
6 Fidelity Series Total Market Index 4.00K 0.11% ▲ 0.00% Apr 30, 2026
7 NT Ext Equity Mkt Index Fund - Lending 3.92K 0.11% ▲ 0.00% Mar 31, 2026
8 Northern Trust Extended Eq Market Idx 3.92K 0.11% ▲ 70.66% Mar 31, 2026
9 Vanguard Instl Ttl Stck Mkt Index Trust 3.89K 0.11% ▲ 0.00% Apr 30, 2026
10 Fidelity Total Market Index 3.63K 0.10% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $-18.39M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $7.50M
EBITDA: $-54.29M
Book Value: $7.41
Earnings/Share: $-16.82
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -66.71%
ROE (TTM): -132.41%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 4.14x 0.03x 0.30x N/A -0.02x
2024-12-31 7.50x 0.01x 0.19x N/A -0.01x
2023-12-31 16.38x 0.01x 0.11x N/A -0.01x
2022-12-31 17.97x 0.00x 0.09x -14.32x -0.01x
2021-12-31 34.48x 0.00x 0.04x -919.03x 0.00x
2020-12-31 27.89x 0.01x 0.04x -225.27x -0.09x
2019-12-31 22.60x 0.02x 0.10x -179.34x -0.15x
2018-12-31 13.19x -0.01x 1.32x N/A -0.03x
2017-12-31 3.02x -0.04x 2.25x N/A -0.06x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NXTC.US!